In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...

The recent rise in H1N1 cases in different states of India has sparked conversation on the effectiveness of the influenza ...

Previously, the COVID-19 immunizations made by Pfizer and Moderna were the only mRNA vaccines on the market.

The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the same technology as many Covid-19 jabs. However, it’s unclear whether insurance ...

Compared with standard flu shots, Moderna’s mFlusiva generates stronger, longer-lasting immunity and is more effective at preventing infection, data show.

What Is mFlusiva, and How Does It Work? The FDA approved mFlusiva to help prevent the flu in adults ages 50 and older. The flu is a viral infection that affects the lungs and breathing airways. It ...

Influenza continues to cause major illness each year in the United States, leading to more than 35,000 deaths annually.

It doesn’t always receive the same attention as the flu, COVID-19, RSV or measles, but pneumonia can be serious and even life ...

New research identifies long-lived lung immune cells that support protective T-cell memory, suggesting galectin-1 could enhance flu vaccines.

A new nanoparticle vaccine could one day give patients immunity to the flu with fewer trips to the doctor and without ...

The flu shot changes each year based on different strains causing the most illnesses, so you need one annually to stay safe.